The US Food and Drug Administration’s electronic Drug Registration and Listing System is a fulcrum for determining OTC monograph user fees while also setting a requirement the agency again has found firms manufacturing and marketing nonprescription drugs aren’t meeting.
The same day that chief of the FDA’s drug user fee programs advised OTC industry stakeholders that providing accurate information...






